LadRx Corp. (LADX)
0.0014
-0.10
(-98.65%)
USD |
OTCM |
Feb 20, 16:00
LadRx SG&A Expense (Quarterly) : 0.6909M for March 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Agenus, Inc. | 10.86M |
| Curis, Inc. | 3.653M |
| Plus Therapeutics, Inc. | 3.443M |
| Windtree Therapeutics, Inc. | 1.855M |
| Enzon Pharmaceuticals, Inc. | 0.229M |